数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   DRIO
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2026-08-11 2026-07-22 2026-08-11 2026-05-13 2026-05-13 2026-03-19
证券总股本 979.95 979.34 734.19 731.24 729.90 730.04
普通股本 979.95 979.34 734.19 731.24 729.90 730.04
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2026-08-11 2026-07-23 2026-06-30 2026-05-12 2026-03-31 2026-03-11
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2026-08-11 979.95 未披露 定期报告 2026-08-11
2026-07-22 979.34 未披露
更多>>
Common stock offered 2,451,490 shares by the company
2026-07-23
2026-08-11 734.19 未披露
更多>>
From March 31, 2026 to June 30, 2026 Issuance of common stock, net of issuance cost Stock-based compensation
2026-06-30
2026-05-13 731.24 未披露 定期报告 2026-05-12
2026-05-13 729.90 未披露
更多>>
From December 31, 2025 to March 31, 2026 Issuance of common stock related to lock up agreement Exercise of pre-funded warrant to common stock Stock-based compensation
2026-03-31
2026-03-19 730.04 未披露 定期报告 2026-03-11
2026-03-19 690.59 未披露
更多>>
From December 31, 2024 to December 31, 2025 Round-up of shares due to reverse share split effectuated on August 28, 2025 Exercise of pre-funded warrant to common stock Issuance of common stock and prefunded warrant, net of issuance cost Conversion of preferred stock to common stock and prefunded warrant Stock-based compensation Issuance of preferred stock, net of issuance cost
2025-12-31
2025-12-22 675.84 未披露 定期报告 2025-12-22
2025-11-13 676.82 未披露
更多>>
From June 30, 2025 to September 30, 2025 Conversion of preferred stock to common stock and prefunded warrant Round-up of shares due to reverse share split effectuated on August 28, 2025 Exercise of prefunded warrant to common stock Stock-based compensation Issuance of common stock and prefunded warrant, net of issuance cost
2025-09-30
2025-09-25 355.42 未披露
更多>>
Common stock offered 1,154,420 shares by the company
2025-09-23
2025-08-25 239.98 未披露
更多>>
each twenty (20) Common Stock will be combined into one (1) Common Stock
2025-08-28
2025-08-25 4799.66 未披露 定期报告 2025-08-25
2025-08-12 4549.70 未披露 定期报告 2025-08-10
2025-07-31 4551.08 3094.23 定期报告 2025-07-30
2025-08-12 4547.49 5.34
更多>>
From March 31, 2025 to June 30, 2025 Conversion of Preferred Stock to Common Stock Stock-based compensation
2025-06-30
2025-05-30 4446.38 5.44 定期报告 2025-05-29
2025-05-28 4446.38 未披露 定期报告 2025-05-26
2025-05-14 4394.94 未披露 定期报告 2025-05-09
2025-05-14 4270.66 5.46
更多>>
From December 31, 2024 to March 31, 2025 Conversion of Preferred Stock to Common Stock Exercise of Prefunded warrants to common stock Stock-based compensation Issuance of preferred stock, net of issuance cost
2025-03-31
2025-03-10 4156.70 5.63 定期报告 2025-03-07
2025-03-10 4156.70 未披露 定期报告 2025-03-03
2025-03-10 3838.84 4.96
更多>>
From December 31, 2023 to December 31, 2024 Exercise of options Exercise of pre-funded warrant to common stock Conversion of preferred stock to common stock Stock-based compensation
2024-12-31
2024-11-07 3409.64 未披露 定期报告 2024-11-05
2024-10-24 3132.39 4.02 定期报告 2024-10-24
2024-11-07 3132.39 4.02
更多>>
From June 30, 2024 to September 30, 2024 Exercise of options Conversion of preferred stock to common stock Stock-based compensation
2024-09-30
2024-08-08 3002.83 未披露 定期报告 2024-08-05
2024-08-08 3002.43 4.03
更多>>
From March 31, 2024 to June 30, 2024 Exercise of options Conversion of preferred stock to common stock Stock-based compensation
2024-06-30
2024-05-15 2992.33 未披露 定期报告 2024-05-10
2024-05-01 2966.68 2.50 定期报告 2024-04-26
2024-04-22 2967.56 未披露 定期报告 2024-04-17
2024-05-15 2943.97 4.14
更多>>
From December 31, 2023 to March 31, 2024 Exercise of options Conversion of prefunded warrants to common Stock Stock-based compensation
2024-03-31
2024-03-28 2944.25 未披露 定期报告 2024-03-22
2024-03-28 2719.18 1.90
更多>>
From December 31, 2022 to December 31, 2023 Exercise of Options Conversion of preferred stock to common stock Issuance of common and preferred stock, net of issuance cost Stock-based compensation Exercise of warrants Common stock related to earnout consideration
2023-12-31
2023-11-02 2721.47 未披露 定期报告 2023-10-31
2023-10-26 2721.88 1.90 定期报告 2023-10-16
2023-10-26 2721.88 未披露 定期报告 2023-10-13
2023-11-02 2721.52 1.90
更多>>
From June 30, 2023 to September 30, 2023 Exercise of warrants Stock-based compensation Issuance of common stock and preferred stock, net of issuance cost
2023-09-30
2023-08-10 2722.95 未披露 定期报告 2023-08-08
2023-08-10 2678.47 1.90 定期报告 2023-06-30
2023-06-29 2678.52 未披露 定期报告 2023-06-26
2023-05-11 2636.13 未披露 定期报告 2023-05-08
2023-05-11 2587.53 0.36
更多>>
From December 31, 2022 to March 31, 2023 Conversion of preferred stock to common stock Stock-based compensation
2023-03-31
2023-03-09 2587.19 未披露 定期报告 2023-03-06
2023-03-09 2572.45 0.36
更多>>
From December 31, 2021 to December 31, 2022 Exercise of warrants Issuance of common stock to directors and employees Issuance of common stock, net of issuance cost upon Acquisitions Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Repurchase and retirement of common stock Stock-based compensation Issuance of common stock, net of issuance cost
2022-12-31
2022-12-30 2567.94 未披露 定期报告 2022-12-28
2022-11-14 2329.68 未披露 定期报告 2022-11-11
2022-10-14 2329.50 0.99 定期报告 2022-10-13
2022-10-14 2329.10 0.99
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock to directors and employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation
2022-09-30
2022-08-15 2297.91 未披露 定期报告 2022-08-10
2022-08-15 2286.00 1.08
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Repurchase and retirement of common stock
2022-06-30
2022-05-12 2198.66 未披露 定期报告 2022-05-09
2022-05-12 2207.10 1.09
更多>>
From December 31, 2021 to March 31, 2022 Exercise of warrants Issuance of common stock to directors and employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock and pre-funded warrants, net of issuance cost Issuance of Common Stock, net of issuance cost upon Acquisition of Physimax Technologies Ltd.
2022-03-31
2022-03-22 2181.50 未披露 定期报告 2022-03-17
2022-03-03 2163.19 未披露
更多>>
1.Securities offered by 4,674,454 shares of common stock and pre-funded warrants to purchase shares 667,559 shares of common stock. 2.Unless indicate otherwise, all information in this prospectus supplement is based on 16,957,456 shares of common stock outstanding as of February 28, 2022
2022-03-03
2022-03-02 1695.75 1.21 定期报告 2022-02-28
2022-03-22 1657.34 1.19
更多>>
From December 31, 2020 to December 31, 2021 Payment for executives and directors under stock for salary program Exercise of Options Exercise of agent warrants Exercise of warrants Issuance of common stock to consultants and service provider Issuance of common stock to directors and employees Conversion of preferred stock to common stock Issuance of common stock, net of issuance cost Issuance of Common Stock, net of issuance cost upon Acquisitions Stock-based compensation
2021-12-31
2021-11-15 1657.56 未披露 定期报告 2021-11-12
2021-10-22 1656.25 1.21 定期报告 2021-10-19
2021-11-15 1650.93 1.21
更多>>
From June 30, 2021 to September 30, 2021 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Directors and Employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation
2021-09-30
2021-08-16 1650.94 未披露 定期报告 2021-08-11
2021-08-16 1633.08 1.21
更多>>
From March 31, 2021 to June 30, 2021 Payment for executives and directors under Stock for Salary Program Exercise of options Exercise of placement agent warrants Exercise of warrants Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock upon acquisition of PsyInnovations Inc.(dba WayForward)
2021-06-30
2021-05-17 1554.32 未披露 定期报告 2021-05-11
2021-04-26 1547.54 0.72 定期报告 2021-04-15
2021-05-17 1539.89 1.24
更多>>
From January 1, 2021 To March 31, 2021 Payment for executives and directors under Stock for Salary Program Exercise of options Exercise of placement agent warrants Exercise of Warrants Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock, net of issuance cost Issuance of common stock upon acquisition of Upright Technologies Ltd.
2021-03-31
2021-04-01 1539.54 未披露 定期报告 2021-03-26
2021-03-09 1527.34 未披露 定期报告 2021-03-05
2021-03-09 811.95 1.58
更多>>
From December 31, 2019 to December 31, 2020 Payment for executives and directors under stock for salary program Exercise of agent warrants Exercise of repriced warrants Issuance of common stock to consultants and service provider Issuance of common stock to directors and employees Deemed dividend related to warrants exchange Conversion of preferred stock to common stock Issuance of common stock, net of issuance cost
2020-12-31
2020-11-12 811.44 未披露 定期报告 2020-11-10
2020-11-12 789.23 1.59
更多>>
From June 30, 2020 to September 30, 2020 Payment for executives and directors under Stock for Salary Program Exercise of Agent Warrants Exercise of repriced Warrants Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock Deemed dividend related to warrants exchange Issuance of Common Stock, net of issuance cost
2020-09-30
2020-09-02 759.09 1.64 定期报告 2020-09-01
2020-09-02 753.13 未披露 定期报告 2020-08-26
2020-08-12 735.30 未披露 定期报告 2020-08-07
2020-08-12 409.91 1.74
更多>>
From March 31, 2020 to June 30, 2020 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock
2020-06-30
2020-05-12 379.32 未披露 定期报告 2020-05-09
2020-05-12 310.36 2.14
更多>>
From January 1, 2020 to March 31, 2020 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock Deemed dividend related to warrants exchange
2020-03-31
2020-03-17 310.14 未披露 定期报告 2020-03-13
2020-03-17 223.56 2.14
更多>>
From December 31, 2018 to December 31, 2019 Payment for executives and directors under Stock for Salary Program Exercise of options Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock and Pre-funded warrants in 2019 Public Offering,net of issuance costs Issuance of Preferred Stock in 2019 private placement, net of issuance cost
2019-12-31
2019-12-27 223.56 1.62 定期报告 2019-12-27
2019-11-15 218.48 未披露
更多>>
Effective as of November 18, 2019, DarioHealth Corp. (the “Company”) will effect a reverse stock split of its outstanding shares of common stock at a ratio of one-for-twenty (the “Reverse Split”). As a result of the Reverse Split, there will be approximately 2,184,842 shares of common stock outstanding (subject to adjustment due to the effect of rounding fractional shares into whole shares).
2019-11-18
2019-10-28 4369.68 未披露 定期报告 2019-10-28
2019-10-28 4368.38 未披露
更多>>
from June 30, 2019 to September 30, 2019 Payment for executives under Stock for Salary Program Issuance of Common Stock to consultants and service provider
2019-09-30
2019-09-30 4368.38 未披露 定期报告 2019-09-19
2019-08-13 4360.13 未披露 定期报告 2019-08-12
2019-08-13 4285.94 未披露
更多>>
From March 31, 2019 to June 30, 2019 Payment for executives and directors under Stock for Salary Program Exercise of Options Public Offering Issuance of Common Stock to directors and employees
2019-06-30
2019-05-24 4285.94 未披露 定期报告 2019-05-24
2019-05-13 3800.40 未披露 定期报告 2019-05-10
2019-05-13 3682.12 未披露
更多>>
From December 31, 2018 to March 31, 2019 Payment for executives and directors under Stock for Salary Program
2019-03-31
2019-03-25 3682.12 未披露 定期报告 2019-03-22
2019-01-15 3660.78 未披露 定期报告 2019-01-14
2019-03-25 3660.78 未披露
更多>>
from December 31, 2017 to December 31, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Directors and Employees Issuance of Common Stock to consultants and service provider Issuance of Common stock in May 2018 warrant exchange agreement Issuance of Common Stock in 2018 Private Placements, net of issuance cost Conversion of Preferred Stock to Common Stock
2018-12-31
2018-10-22 2593.62 未披露 定期报告 2018-10-12
2018-11-13 2569.17 189.03
更多>>
from December 31, 2017 to September 30, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock and warrants, net of issuance cost Deemed dividend related to May 2018 warrant exchange agreement Conversion of Preferred Stock to Common Stock Issuance of Common Stock to directors and employees Issuance of Preferred Stock and warrants, net of issuance cost
2018-09-30
2018-08-09 2134.16 未披露 定期报告 2018-08-07
2018-08-10 2108.14 未披露
更多>>
From December 31, 2017 to June 30, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock, net of issuance cost Deemed dividend related to May 2018 warrant exchange agreement Conversion of Preferred Stock to Common Stock Issuance of Common Stock to directors and employees Issuance of Preferred Stock, net of issuance cost
2018-06-30
2018-04-26 1674.39 未披露 定期报告 2018-04-25
2018-05-15 1648.02 未披露
更多>>
From December 31, 2017 to March 31, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock, net of issuance cost Issuance of Preferred Stock, net of issuance cost
2018-03-31
2018-04-12 1648.02 未披露 定期报告 2018-03-26
2018-03-19 1644.79 未披露 定期报告 2018-03-18
2018-03-19 1407.42 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of Common Stock in January 2017 Private Placement, net of issuance cost Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock in March 2017 Private Placement, net of issuance cost Issuance of Common Stock in April 2017 Public offering, net of issuance cost Exercise of options Issuance of Common Stock in August 2017 Private Placement, net of issuance cost Issuance of Common stock in November 2017 warrant exchange agreement Conversion of Preferred Stock to Common Stock Deemed dividend related to Stock dividend Issuance of Preferred Stock in August 2017 Private placement, net of issuance cost
2017-12-31
2017-11-14 1035.24 未披露 定期报告 2017-11-10
2017-11-14 1023.82 230.77
更多>>
From December 31, 2016 To September 30, 2017 Issuance of Common Stock in January 2017 Private Placement, net of issuance cost Payment for executives and directors under Stock for Salary Program Issuance of Common Stock in to Employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock in March 2017 Private Placement, net of issuance cost Issuance of Common Stock in April 2017 Public offering, net of issuance cost Exercise of options Issuance of Common Stock in August 2017 Private Placement, net of issuance cost
2017-09-30
2017-08-25 957.49 未披露 定期报告 2017-08-16
2017-08-14 975.49 未披露 定期报告 2017-08-11
2017-08-14 959.92 未披露 定期报告 2017-06-30
2017-05-15 958.24 未披露 定期报告 2017-05-12
2017-05-15 797.65 未披露 定期报告 2017-03-31
2017-03-22 797.65 未披露 定期报告 2017-03-21
2017-03-10 726.90 未披露 定期报告 2017-03-09
2017-02-13 726.40 未披露 定期报告 2017-02-03
2016-11-10 571.34 未披露
更多>>
From December 31, 2015 to September 30, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives, employee and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Exercise of options Deemed dividend related to Series A Preferred Stock exchange agreement into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
2016-09-30
2016-08-11 571.34 未披露 定期报告 2016-08-09
2016-08-11 568.84 未披露
更多>>
from December 31, 2015 to June 30, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Exercise of options Deemed dividend related to change in the conversion terms of Series A Preferred Stock into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
2016-06-30
2016-05-11 558.12 未披露 定期报告 2016-05-09
2016-05-11 557.56 未披露
更多>>
from December 31, 2015 to March 31, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Deemed dividend related to change in the conversion terms of Series A Preferred Stock into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
2016-03-31
2016-03-07 555.42 未披露
更多>>
The number of shares of common stock that will be outstanding after this offering set forth above is based on 3,597,200 shares of common stock outstanding as of March 3, 2016 (giving pro forma effect to the concurrent private placement of 555,555 shares of common stock and the issuance of 44,444 restricted shares of common stock to a finder in connection with the concurrent private placement), and excludes the following:
2016-03-04
2016-02-08 5349.86 未披露 定期报告 2016-02-08
2016-02-08 5240.71 3.56
更多>>
from December 31, 2014 to December 31, 2015 Issuance of Common Stock and warrants in February 2015 at $0.18 per unit, net of issuance cost Issuance of Common Stock in July and August 2015 at $0.30 per unit, net of issuance cost Issuance of Common stock in November 2015 at $0.30 per unit, net of issuance cost Issuance of Common stock in December 2015 at $0.34 per unit, net of issuance cost Issuance of Common Stock in April, August and December 2015 to service provide Issuance of Common Stock in September 2015 to employees as compensation Issuance of Common Stock in September 2015 to service provider Payment for executives and directors under Salary Program Exercise of warrants into Common Stock in May 2015, net of issuance cost Conversion of Series A Preferred Stock into Common Stock Exercise of warrants Exercise of options
2015-12-31
2016-01-15 4276.83 未披露
更多>>
From December 31, 2014 to September 30, 2015 Issuance of Common Stock and warrants in February 2015 at $0.18 per unit, net of issuance cost Issuance of Common Stock in July and August 2015, net of issuance cost Issuance of Common Stock in April and August 2015 to service provider Issuance of Common Stock in September 2015 to employees Issuance of Common Stock in September 2015 to service provider Payment for executives and directors under Salary Program Exercise of warrants into Common Stock in May 2015, net of issuance cost Conversion of Series A Preferred Stock into Common Stock Exercise of options into Common Stock
2015-09-30
Common stock offered 2,451,490 shares by the company
From March 31, 2026 to June 30, 2026 Issuance of common stock, net of issuance cost Stock-based compensation
From December 31, 2025 to March 31, 2026 Issuance of common stock related to lock up agreement Exercise of pre-funded warrant to common stock Stock-based compensation
From December 31, 2024 to December 31, 2025 Round-up of shares due to reverse share split effectuated on August 28, 2025 Exercise of pre-funded warrant to common stock Issuance of common stock and prefunded warrant, net of issuance cost Conversion of preferred stock to common stock and prefunded warrant Stock-based compensation Issuance of preferred stock, net of issuance cost
From June 30, 2025 to September 30, 2025 Conversion of preferred stock to common stock and prefunded warrant Round-up of shares due to reverse share split effectuated on August 28, 2025 Exercise of prefunded warrant to common stock Stock-based compensation Issuance of common stock and prefunded warrant, net of issuance cost
Common stock offered 1,154,420 shares by the company
each twenty (20) Common Stock will be combined into one (1) Common Stock
From March 31, 2025 to June 30, 2025 Conversion of Preferred Stock to Common Stock Stock-based compensation
From December 31, 2024 to March 31, 2025 Conversion of Preferred Stock to Common Stock Exercise of Prefunded warrants to common stock Stock-based compensation Issuance of preferred stock, net of issuance cost
From December 31, 2023 to December 31, 2024 Exercise of options Exercise of pre-funded warrant to common stock Conversion of preferred stock to common stock Stock-based compensation
From June 30, 2024 to September 30, 2024 Exercise of options Conversion of preferred stock to common stock Stock-based compensation
From March 31, 2024 to June 30, 2024 Exercise of options Conversion of preferred stock to common stock Stock-based compensation
From December 31, 2023 to March 31, 2024 Exercise of options Conversion of prefunded warrants to common Stock Stock-based compensation
From December 31, 2022 to December 31, 2023 Exercise of Options Conversion of preferred stock to common stock Issuance of common and preferred stock, net of issuance cost Stock-based compensation Exercise of warrants Common stock related to earnout consideration
From June 30, 2023 to September 30, 2023 Exercise of warrants Stock-based compensation Issuance of common stock and preferred stock, net of issuance cost
From December 31, 2022 to March 31, 2023 Conversion of preferred stock to common stock Stock-based compensation
From December 31, 2021 to December 31, 2022 Exercise of warrants Issuance of common stock to directors and employees Issuance of common stock, net of issuance cost upon Acquisitions Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Repurchase and retirement of common stock Stock-based compensation Issuance of common stock, net of issuance cost
From June 30, 2022 to September 30, 2022 Issuance of common stock to directors and employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation
From March 31, 2022 to June 30, 2022 Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Repurchase and retirement of common stock
From December 31, 2021 to March 31, 2022 Exercise of warrants Issuance of common stock to directors and employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock and pre-funded warrants, net of issuance cost Issuance of Common Stock, net of issuance cost upon Acquisition of Physimax Technologies Ltd.
1.Securities offered by 4,674,454 shares of common stock and pre-funded warrants to purchase shares 667,559 shares of common stock. 2.Unless indicate otherwise, all information in this prospectus supplement is based on 16,957,456 shares of common stock outstanding as of February 28, 2022
From December 31, 2020 to December 31, 2021 Payment for executives and directors under stock for salary program Exercise of Options Exercise of agent warrants Exercise of warrants Issuance of common stock to consultants and service provider Issuance of common stock to directors and employees Conversion of preferred stock to common stock Issuance of common stock, net of issuance cost Issuance of Common Stock, net of issuance cost upon Acquisitions Stock-based compensation
From June 30, 2021 to September 30, 2021 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Directors and Employees Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation
From March 31, 2021 to June 30, 2021 Payment for executives and directors under Stock for Salary Program Exercise of options Exercise of placement agent warrants Exercise of warrants Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock upon acquisition of PsyInnovations Inc.(dba WayForward)
From January 1, 2021 To March 31, 2021 Payment for executives and directors under Stock for Salary Program Exercise of options Exercise of placement agent warrants Exercise of Warrants Issuance of common stock to consultants and service provider Conversion of preferred stock to common stock Stock-based compensation Issuance of common stock, net of issuance cost Issuance of common stock upon acquisition of Upright Technologies Ltd.
From December 31, 2019 to December 31, 2020 Payment for executives and directors under stock for salary program Exercise of agent warrants Exercise of repriced warrants Issuance of common stock to consultants and service provider Issuance of common stock to directors and employees Deemed dividend related to warrants exchange Conversion of preferred stock to common stock Issuance of common stock, net of issuance cost
From June 30, 2020 to September 30, 2020 Payment for executives and directors under Stock for Salary Program Exercise of Agent Warrants Exercise of repriced Warrants Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock Deemed dividend related to warrants exchange Issuance of Common Stock, net of issuance cost
From March 31, 2020 to June 30, 2020 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock
From January 1, 2020 to March 31, 2020 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Conversion of Preferred Stock to Common Stock Deemed dividend related to warrants exchange
From December 31, 2018 to December 31, 2019 Payment for executives and directors under Stock for Salary Program Exercise of options Issuance of Common Stock to directors and employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock and Pre-funded warrants in 2019 Public Offering,net of issuance costs Issuance of Preferred Stock in 2019 private placement, net of issuance cost
Effective as of November 18, 2019, DarioHealth Corp. (the “Company”) will effect a reverse stock split of its outstanding shares of common stock at a ratio of one-for-twenty (the “Reverse Split”). As a result of the Reverse Split, there will be approximately 2,184,842 shares of common stock outstanding (subject to adjustment due to the effect of rounding fractional shares into whole shares).
from June 30, 2019 to September 30, 2019 Payment for executives under Stock for Salary Program Issuance of Common Stock to consultants and service provider
From March 31, 2019 to June 30, 2019 Payment for executives and directors under Stock for Salary Program Exercise of Options Public Offering Issuance of Common Stock to directors and employees
From December 31, 2018 to March 31, 2019 Payment for executives and directors under Stock for Salary Program
from December 31, 2017 to December 31, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Directors and Employees Issuance of Common Stock to consultants and service provider Issuance of Common stock in May 2018 warrant exchange agreement Issuance of Common Stock in 2018 Private Placements, net of issuance cost Conversion of Preferred Stock to Common Stock
from December 31, 2017 to September 30, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock and warrants, net of issuance cost Deemed dividend related to May 2018 warrant exchange agreement Conversion of Preferred Stock to Common Stock Issuance of Common Stock to directors and employees Issuance of Preferred Stock and warrants, net of issuance cost
From December 31, 2017 to June 30, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock, net of issuance cost Deemed dividend related to May 2018 warrant exchange agreement Conversion of Preferred Stock to Common Stock Issuance of Common Stock to directors and employees Issuance of Preferred Stock, net of issuance cost
From December 31, 2017 to March 31, 2018 Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to consultants and service provider Issuance of Common Stock, net of issuance cost Issuance of Preferred Stock, net of issuance cost
from December 31, 2016 to December 31, 2017 Issuance of Common Stock in January 2017 Private Placement, net of issuance cost Payment for executives and directors under Stock for Salary Program Issuance of Common Stock to Employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock in March 2017 Private Placement, net of issuance cost Issuance of Common Stock in April 2017 Public offering, net of issuance cost Exercise of options Issuance of Common Stock in August 2017 Private Placement, net of issuance cost Issuance of Common stock in November 2017 warrant exchange agreement Conversion of Preferred Stock to Common Stock Deemed dividend related to Stock dividend Issuance of Preferred Stock in August 2017 Private placement, net of issuance cost
From December 31, 2016 To September 30, 2017 Issuance of Common Stock in January 2017 Private Placement, net of issuance cost Payment for executives and directors under Stock for Salary Program Issuance of Common Stock in to Employees Issuance of Common Stock to consultants and service provider Issuance of Common Stock in March 2017 Private Placement, net of issuance cost Issuance of Common Stock in April 2017 Public offering, net of issuance cost Exercise of options Issuance of Common Stock in August 2017 Private Placement, net of issuance cost
From December 31, 2015 to September 30, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives, employee and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Exercise of options Deemed dividend related to Series A Preferred Stock exchange agreement into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
from December 31, 2015 to June 30, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Exercise of options Deemed dividend related to change in the conversion terms of Series A Preferred Stock into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
from December 31, 2015 to March 31, 2016 Issuance of Common Stock in March 2016 Public Offering, net of issuance cost Issuance of Common Stock in March 2016 Private Placement, net of issuance cost Issuance of Common Stock in January 2016 to service provider Payment for executives and directors under Salary Program Issuance of Common Stock in March 2016 to officer Exercise of warrants into Common Stock, net of issuance cost Deemed dividend related to change in the conversion terms of Series A Preferred Stock into Common Stock in March 2016 Conversion of Series A Preferred Stock into Common Stock On February 17, 2016, the Company’s Board of Directors approved a reverse split in a ratio of one-to-eighteen. The 2016 reverse split was implemented on February 26, 2016 (the "2016 Reverse Split").
The number of shares of common stock that will be outstanding after this offering set forth above is based on 3,597,200 shares of common stock outstanding as of March 3, 2016 (giving pro forma effect to the concurrent private placement of 555,555 shares of common stock and the issuance of 44,444 restricted shares of common stock to a finder in connection with the concurrent private placement), and excludes the following:
from December 31, 2014 to December 31, 2015 Issuance of Common Stock and warrants in February 2015 at $0.18 per unit, net of issuance cost Issuance of Common Stock in July and August 2015 at $0.30 per unit, net of issuance cost Issuance of Common stock in November 2015 at $0.30 per unit, net of issuance cost Issuance of Common stock in December 2015 at $0.34 per unit, net of issuance cost Issuance of Common Stock in April, August and December 2015 to service provide Issuance of Common Stock in September 2015 to employees as compensation Issuance of Common Stock in September 2015 to service provider Payment for executives and directors under Salary Program Exercise of warrants into Common Stock in May 2015, net of issuance cost Conversion of Series A Preferred Stock into Common Stock Exercise of warrants Exercise of options
From December 31, 2014 to September 30, 2015 Issuance of Common Stock and warrants in February 2015 at $0.18 per unit, net of issuance cost Issuance of Common Stock in July and August 2015, net of issuance cost Issuance of Common Stock in April and August 2015 to service provider Issuance of Common Stock in September 2015 to employees Issuance of Common Stock in September 2015 to service provider Payment for executives and directors under Salary Program Exercise of warrants into Common Stock in May 2015, net of issuance cost Conversion of Series A Preferred Stock into Common Stock Exercise of options into Common Stock